Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Nov 17:14:1269307.
doi: 10.3389/fpsyt.2023.1269307. eCollection 2023.

Editorial: The pros and cons of psychotropic drug-induced changes in periphery and central nervous system: elucidating structural and molecular mechanisms

Affiliations
Editorial

Editorial: The pros and cons of psychotropic drug-induced changes in periphery and central nervous system: elucidating structural and molecular mechanisms

Roberto Esposito et al. Front Psychiatry. .
No abstract available

Keywords: brain structure abnormalities; cognitive function; genetic and environmental factors; neurotransmission; oxidative stress; peripheral metabolism; psychotropic drugs; treatment response.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Comment on

  • Editorial on the Research Topic The pros and cons of psychotropic drug-induced changes in periphery and central nervous system: elucidating structural and molecular mechanisms

Similar articles

References

    1. Cao T, Li NN, Cai HL. Candidate metabolic biomarkers for schizophrenia in CNS and periphery: do any possible associations exist? Schizophr Res. (2020) 226:95–110. 10.1016/j.schres.2019.03.009 - DOI - PubMed
    1. Romba C, Perez-Reisler M. Management of adverse effects of psychotropic medications. Pediatr Ann. (2020) 49:e431–5. 10.3928/19382359-20200922-03 - DOI - PubMed
    1. Worbe Y. Neuroimaging signature of neuropsychiatric disorders. Curr Opin Neurol. (2015) 28:358–64. 10.1097/WCO.0000000000000220 - DOI - PubMed
    1. Kraguljac NV, McDonald WM, Widge AS, Rodriguez CI, Tohen M, Nemeroff CB. Neuroimaging biomarkers in schizophrenia. Am J Psychiatry. (2021) 178:509–21. 10.1176/appi.ajp.2020.20030340 - DOI - PMC - PubMed
    1. Tulay EE, Metin B, Tarhan N, Arikan MK. Multimodal neuroimaging: basic concepts and classification of neuropsychiatric diseases. Clin EEG Neurosci. (2019) 50:20–33. 10.1177/1550059418782093 - DOI - PubMed

Publication types